‘Overpriced’ Antifungal Drug Seized In Kothagudem

Hyderabad: As part of stepped-up surveillance against overcharging of essential medicines, the Drugs Control Administration (DCA), Telangana, officials have seized ‘overpriced’ antifungal drug ‘GRISOLAB-250’ Griseofulvin tablets-250 mg during a surprise check in Kothagudem on Tuesday.

The worth of the stock seized during the raid is ₹4,095, according to a press release. The seized product, manufactured by Laborate Pharmaceuticals India Ltd, Himachal Pradesh, and marketed by Gpp Axalade, Salwan, Haryana, bears MRP as ₹65 for 10 tablets on the label of the product, which is a violation of Drugs (Prices Control) Order, 2013, the press release added. The ceiling price fixed by the Central government for the product ‘Griseofulvin tablets-250 mg’ is ₹17.7 for 10 tablets. Hence, the MRP i.e., including GST 12% should not be more than ₹19.83 for 10 tablets.

However, the pharmaceutical firm ‘overpriced’ the product. A strip of tablets has been charged excess of ₹45.17 per 10 tablets. Further investigation into the matter is underway and action will be taken against all the offenders as per the law, the DCA officials said.

In a separate incident, the DCA sleuths raided a medical shop named ‘Amaan Medical and General Stores’ allegedly operating without drug licence at Jaklair village in Narayanpet district. The officials seized an unauthorised stock of medicines including antibiotic injections, IV fluids, analgesics, antihypersensitive drugs and cough syrups worth ₹ 1.20 lakh. Further investigation is in progress.

Related Posts

  • Pharma
  • July 26, 2024
  • 118 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 108 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD